![5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester](https://static.cymitquimica.com/products/3D/img/YKB22495.png "Cliquez pour agrandir")
5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester
CAS : 898224-95-8
Ref. 3D-YKB22495
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Informations sur le produit
Bendamustine is a drug that belongs to the class of alkylating agents. It is used in the treatment of cancer and chronic lymphocytic leukemia. Bendamustine is a synthetic compound, which has been shown to have oncosis (cancer-causing) properties. Bendamustine can be administered intravenously as a dry powder or in tablet form and has shown efficacy against neoplastic cells. Its mechanism of action involves binding to DNA and inhibiting the synthesis of RNA and DNA, thereby interfering with cell division. The drug also binds to erythrocytes, leading to methemoglobinemia. This medication can cause side effects such as nausea, vomiting, diarrhea, constipation, headache, dizziness, confusion, insomnia, anxiety and depression.
Propriétés chimiques
Question d’ordre technique sur : 3D-YKB22495 5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
